Senior Scientist, Quantitative PK/PD & Pharmacometrics Hybrid

Merck; Rahway (NJ); Hybrid; USD 129,000 - 203,000; Full time

Job summary

Merck is seeking a Senior Scientist in Quantitative Pharmacology and Pharmacometrics (QP2) to support cardiometabolic and ophthalmology programs in Rahway, NJ/West Point, PA. You will lead quantitative analyses, collaborate with cross-functional teams, and contribute to end-to-end drug development.

The role emphasizes model-based strategies, translational PK/PD, and strong communication skills to drive portfolio decisions and program success in a leading biopharmaceutical setting.

Qualifications

• Ph.D. or PharmD or MS with relevant experience in pharmaceutical drug development, regulation, or academia.
• Educational background in biopharmaceutics, pharmaceutical sciences, pharmacometrics, or related field.
• Experience performing population PK/PKPD analyses using standard pharmacometrics software (NONMEM, Monolix, Phoenix, etc).
• Strong written and verbal communication and interdisciplinary collaboration.

Responsibilities

• Contribute to model-based strategies for quantitative analyses to inform drug discovery and development.
• Represent QP2 on cardiometabolic and ophthalmology programs across discovery and development teams.
• Collaborate with internal and external partners on study design, execution, and data interpretation.

Skills

Population PK/PD

Pharmacometric analysis

Communication

Cross-functional collaboration

Drug discovery knowledge

Education

Ph.D. or PharmD

MS with relevant experience

Tools

NONMEM

Monolix

Phoenix

Job description

Merck is seeking a Senior Scientist in Quantitative Pharmacology and Pharmacometrics (QP2) to support cardiometabolic and ophthalmology programs in Rahway, NJ/West Point, PA. You will lead quantitative analyses, collaborate with cross-functional teams, and contribute to end-to-end drug development.

The role emphasizes model-based strategies, translational PK/PD, and strong communication skills to drive portfolio decisions and program success in a leading biopharmaceutical setting.